Close

Regenxbio (RGNX) to Acquire Dimension Therapeutics (DMTX) in All-Stock Transaction

August 25, 2017 8:01 AM EDT Send to a Friend
REGENXBIO Inc. (Nasdaq: RGNX) and Dimension Therapeutics, Inc. (Nasdaq: DMTX) today announced that they have entered into a definitive agreement ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login